Skip to main content
Top
Published in: Clinical Research in Cardiology 9/2020

01-09-2020 | Transcatheter Aortic Valve Implantation | Original Paper

Transcatheter aortic valve implantation in nonagenarians: insights from the German Aortic Valve Registry (GARY)

Authors: J. Blumenstein, H. Möllmann, S. Bleiziffer, T. Bauer, S. Ensminger, R. Bekeredjian, T. Walther, C. Frerker, F. Beyersdorf, C. Hamm, A. Beckmann

Published in: Clinical Research in Cardiology | Issue 9/2020

Login to get access

Abstract

Objective

The aim of this study was to compare the outcome of nonagenarians (≥ 90 years) with that of younger (< 90 years) patients undergoing transcatheter aortic valve implantation (TAVI) in current practice.

Methods

Data are collected from the German Aortic Valve Registry (GARY), which was designed to evaluate current practice in the invasive treatment of patients with aortic valve diseases in Germany. Data were analyzed regarding procedural outcome, 30-day, and 1-year outcomes of nonagenarians in comparison to that of younger patients.

Results

Between 2011 and 2015, 2436/33,051 (7.3%) nonagenarians underwent TAVI and were included in GARY. Nonagenarians were significantly more often male (45.2% vs. 40.0%, p < 0.001), frail (38.7% vs. 34.7%, p < 0.001), and had higher EuroSCORE scores than younger patient group (23.2% vs. 17.0%). Nonagenarians were significantly less often treated via transapical access (16.3% vs. 22.3%, p < 0.001). Procedure was performed significantly less often in general anesthesia (58.2% vs. 60.7%, p = 0.02) in nonagenarians, while necessity of pacemaker implantation was significantly higher in nonagenarians (27.2% vs. 24.8%, p > 0.001). The incidence of other typical postprocedural complications such as severe bleeding events and vascular complications were comparable between groups. However, 30-day (5.2% vs. 3.9%) and 1-year (22.7% vs. 17.7%) mortality rates were significantly higher among nonagenarians and age ≥ 90 years could be identified as an isolated risk factor for mortality.

Conclusion

TAVI is a highly standardized procedure that can be performed safely with high procedural success even in very old patients. Although mortality is significantly higher in these patients—most probably due to the intrinsic higher risk profile of the very old patients—the results are still acceptable. To optimize outcome, especially elderly patients seem to profit from a procedure under local anesthesia or conscious sedation, to minimize the rate of postoperative delirium and the length of stay and to facilitate early mobilization.
Literature
1.
go back to reference Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005–1011CrossRef Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005–1011CrossRef
2.
go back to reference Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG (2016) PARTNER 2 investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk Patients. N Engl J Med. 374:1609–1620CrossRef Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG (2016) PARTNER 2 investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk Patients. N Engl J Med. 374:1609–1620CrossRef
3.
go back to reference Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim W-K, Nef H, Husser O, Elsässer A, Hamm CW, Möllmann H (2018) Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J. 39:667–675CrossRef Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim W-K, Nef H, Husser O, Elsässer A, Hamm CW, Möllmann H (2018) Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J. 39:667–675CrossRef
4.
go back to reference Möllmann H, Bestehorn K, Bestehorn M, Papoutsis K, Fleck E, Ertl G, Kuck K-H, Hamm C (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 Germany. Clin Res Cardiol 105:553–559CrossRef Möllmann H, Bestehorn K, Bestehorn M, Papoutsis K, Fleck E, Ertl G, Kuck K-H, Hamm C (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 Germany. Clin Res Cardiol 105:553–559CrossRef
5.
go back to reference Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR (2019) PARTNER 3 investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 380:1695–1705CrossRef Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR (2019) PARTNER 3 investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 380:1695–1705CrossRef
6.
go back to reference Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL 3rd, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ (2019) Evolut low risk trial investigators. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 380:1706–1715CrossRef Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL 3rd, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ (2019) Evolut low risk trial investigators. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 380:1706–1715CrossRef
7.
go back to reference Arsalan M, Szerlip M, Vemulapalli S, Holper EM, Arnold SV, Li Z, DiMaio MJ, Rumsfeld JS, Brown DL, Mack MJ (2016) Should transcatheter aortic valve replacement be performed in nonagenarians?: insights from the STS/ACC TVT registry. J Am Coll Cardiol. 67:1387–1395CrossRef Arsalan M, Szerlip M, Vemulapalli S, Holper EM, Arnold SV, Li Z, DiMaio MJ, Rumsfeld JS, Brown DL, Mack MJ (2016) Should transcatheter aortic valve replacement be performed in nonagenarians?: insights from the STS/ACC TVT registry. J Am Coll Cardiol. 67:1387–1395CrossRef
8.
go back to reference Mack MC, Szerlip M, Herbert M, Akram S, Kim R, Prince B, Harrington KB, Mack M, Holper E (2014) Outcome of treatment of nonagenarians with severe aortic stenosis. J Am Coll Cardiol. 63:A1935CrossRef Mack MC, Szerlip M, Herbert M, Akram S, Kim R, Prince B, Harrington KB, Mack M, Holper E (2014) Outcome of treatment of nonagenarians with severe aortic stenosis. J Am Coll Cardiol. 63:A1935CrossRef
9.
go back to reference Noble S, Frangos E, Samaras N, Ellenberger C, Frangos C, Cikirikcioglu M, Bendjelid K, Frei A, Myers P, Licker M, Roffi M (2013) Transcatheter aortic valve implantation in nonagenarians: effective and safe. Eur J Intern Med. 24:750–755CrossRef Noble S, Frangos E, Samaras N, Ellenberger C, Frangos C, Cikirikcioglu M, Bendjelid K, Frei A, Myers P, Licker M, Roffi M (2013) Transcatheter aortic valve implantation in nonagenarians: effective and safe. Eur J Intern Med. 24:750–755CrossRef
10.
go back to reference Yamamoto M, Meguro K, Mouillet G, Bergoend E, Monin J-L, Lim P, Dubois-Rande J-L, Teiger E (2012) Comparison of effectiveness and safety of transcatheter aortic valve implantation in patients aged ≥90 years versus %3c90 years. Am J Cardiol. 110:1156–1163CrossRef Yamamoto M, Meguro K, Mouillet G, Bergoend E, Monin J-L, Lim P, Dubois-Rande J-L, Teiger E (2012) Comparison of effectiveness and safety of transcatheter aortic valve implantation in patients aged ≥90 years versus %3c90 years. Am J Cardiol. 110:1156–1163CrossRef
11.
go back to reference Lange R, Beckmann A, Neumann T, Krane M, Deutsch M-A, Landwehr S, Kötting J, Welz A, Zahn R, Cremer J, Figulla HR, Schuler G, Holzhey DM, Funkat A-K, Heusch G, Sack S, Pasic M, Meinertz T, Walther T, Kuck K-H, Beyersdorf F, Böhm M, Möllmann H, Hamm CW, Mohr FW (2016) GARY executive board. Quality of life after transcatheter aortic valve replacement: prospective data from GARY (German Aortic Valve Registry). JACC Cardiovasc Interv. 9:2541–2554CrossRef Lange R, Beckmann A, Neumann T, Krane M, Deutsch M-A, Landwehr S, Kötting J, Welz A, Zahn R, Cremer J, Figulla HR, Schuler G, Holzhey DM, Funkat A-K, Heusch G, Sack S, Pasic M, Meinertz T, Walther T, Kuck K-H, Beyersdorf F, Böhm M, Möllmann H, Hamm CW, Mohr FW (2016) GARY executive board. Quality of life after transcatheter aortic valve replacement: prospective data from GARY (German Aortic Valve Registry). JACC Cardiovasc Interv. 9:2541–2554CrossRef
12.
go back to reference Green P, Woglom AE, Genereux P, Daneault B, Paradis J-M, Schnell S, Hawkey M, Maurer MS, Kirtane AJ, Kodali S, Moses JW, Leon MB, Smith CR, Williams M (2012) The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv. 5:974–981CrossRef Green P, Woglom AE, Genereux P, Daneault B, Paradis J-M, Schnell S, Hawkey M, Maurer MS, Kirtane AJ, Kodali S, Moses JW, Leon MB, Smith CR, Williams M (2012) The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv. 5:974–981CrossRef
13.
go back to reference Stortecky S, Schoenenberger AW, Moser A, Kalesan B, Jüni P, Carrel T, Bischoff S, Schoenenberger C-M, Stuck AE, Windecker S, Wenaweser P (2012) Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 5:489–496CrossRef Stortecky S, Schoenenberger AW, Moser A, Kalesan B, Jüni P, Carrel T, Bischoff S, Schoenenberger C-M, Stuck AE, Windecker S, Wenaweser P (2012) Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 5:489–496CrossRef
14.
go back to reference Beckmann A, Hamm C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler GC, Walther T, Beyersdorf F, Böhm M, Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Mohr FW (2012) GARY executive board. The German Aortic Valve Registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg. 60:319–325CrossRef Beckmann A, Hamm C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler GC, Walther T, Beyersdorf F, Böhm M, Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Mohr FW (2012) GARY executive board. The German Aortic Valve Registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg. 60:319–325CrossRef
15.
go back to reference Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es G-A, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB (2012) Valve academic research consortium (VARC)-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 42:S45–60CrossRef Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es G-A, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB (2012) Valve academic research consortium (VARC)-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 42:S45–60CrossRef
16.
go back to reference Beckmann A, Meyer R, Lewandowski J, Frie M, Markewitz A, Harringer W (2018) German heart surgery report 2017: the annual updated registry of the german society for thoracic and cardiovascular surgery. Thorac Cardiovasc Surg. 66:608–621CrossRef Beckmann A, Meyer R, Lewandowski J, Frie M, Markewitz A, Harringer W (2018) German heart surgery report 2017: the annual updated registry of the german society for thoracic and cardiovascular surgery. Thorac Cardiovasc Surg. 66:608–621CrossRef
17.
go back to reference Abramowitz Y, Chakravarty T, Jilaihawi H, Kashif M, Zadikany R, Lee C, Matar G, Cheng W, Makkar RR (2015) Comparison of outcomes of transcatheter aortic valve implantation in patients ≥90 years versus %3c90 years. Am J Cardiol. 116:1110–1115CrossRef Abramowitz Y, Chakravarty T, Jilaihawi H, Kashif M, Zadikany R, Lee C, Matar G, Cheng W, Makkar RR (2015) Comparison of outcomes of transcatheter aortic valve implantation in patients ≥90 years versus %3c90 years. Am J Cardiol. 116:1110–1115CrossRef
18.
go back to reference Havakuk O, Finkelstein A, Steinvil A, Halkin A, Arbel Y, Abramowitz Y, Ben Assa E, Konigstein M, Keren G, Banai S (2014) Comparison of outcomes in patients ≤85 versus %3e85 years of age undergoing transcatheter aortic-valve implantation. Am J Cardiol. 113:138–141CrossRef Havakuk O, Finkelstein A, Steinvil A, Halkin A, Arbel Y, Abramowitz Y, Ben Assa E, Konigstein M, Keren G, Banai S (2014) Comparison of outcomes in patients ≤85 versus %3e85 years of age undergoing transcatheter aortic-valve implantation. Am J Cardiol. 113:138–141CrossRef
19.
go back to reference Yamamoto M, Mouillet G, Meguro K, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leuguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande J-L, Teiger E (2014) FRANCE-2 registry investigators. Clinical results of transcatheter aortic valve implantation in octogenarians and nonagenarians: insights from the FRANCE-2 registry. Ann Thorac Surg. 97:29–36CrossRef Yamamoto M, Mouillet G, Meguro K, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leuguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande J-L, Teiger E (2014) FRANCE-2 registry investigators. Clinical results of transcatheter aortic valve implantation in octogenarians and nonagenarians: insights from the FRANCE-2 registry. Ann Thorac Surg. 97:29–36CrossRef
20.
go back to reference Steinvil A, Leshem-Rubinow E, Halkin A, Abramowitz Y, Ben-Assa E, Shacham Y, Bar-Dayan A, Keren G, Banai S, Finkelstein A (2015) Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions. Am J Cardiol. 115:100–106CrossRef Steinvil A, Leshem-Rubinow E, Halkin A, Abramowitz Y, Ben-Assa E, Shacham Y, Bar-Dayan A, Keren G, Banai S, Finkelstein A (2015) Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions. Am J Cardiol. 115:100–106CrossRef
21.
go back to reference Barbash IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, Abramowitz Y, Latib A, Nguyen C, Deuschl F, Segev A, Sideris K, Buccheri S, Simonato M, Rosa FD, Tamburino C, Jilaihawi H, Miyazaki T, Himbert D, Schofer N, Guetta V, Bleiziffer S, Tchetche D, Immè S, Makkar RR, Vahanian A, Treede H, Lange R, Colombo A, Dvir D (2015) Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. Eur Heart J 36:3370–3379 Barbash IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, Abramowitz Y, Latib A, Nguyen C, Deuschl F, Segev A, Sideris K, Buccheri S, Simonato M, Rosa FD, Tamburino C, Jilaihawi H, Miyazaki T, Himbert D, Schofer N, Guetta V, Bleiziffer S, Tchetche D, Immè S, Makkar RR, Vahanian A, Treede H, Lange R, Colombo A, Dvir D (2015) Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. Eur Heart J 36:3370–3379
22.
go back to reference Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P, Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D’Agostino RB Jr, Leon MB (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 387:2218–2225CrossRef Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P, Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D’Agostino RB Jr, Leon MB (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 387:2218–2225CrossRef
23.
go back to reference Gaede L, Kim W-K, Liebetrau C, Dörr O, Sperzel J, Blumenstein J, Berkowitsch A, Walther T, Hamm C, Elsässer A, Nef H, Möllmann H (2018) Pacemaker implantation after TAVI: predictors of AV block persistence. Clin Res Cardiol. 107:60–69CrossRef Gaede L, Kim W-K, Liebetrau C, Dörr O, Sperzel J, Blumenstein J, Berkowitsch A, Walther T, Hamm C, Elsässer A, Nef H, Möllmann H (2018) Pacemaker implantation after TAVI: predictors of AV block persistence. Clin Res Cardiol. 107:60–69CrossRef
24.
go back to reference Barbanti M, Gulino S, Costa G, Tamburino C (2017) Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation. Expert Rev Med Devices. 14:135–147CrossRef Barbanti M, Gulino S, Costa G, Tamburino C (2017) Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation. Expert Rev Med Devices. 14:135–147CrossRef
25.
go back to reference Urena M, Webb JG, Tamburino C, Muñoz-García AJ, Cheema A, Dager AE, Serra V, Amat-Santos IJ, Barbanti M, Immè S, Briales JHA, Benitez LM, Al Lawati H, Cucalon AM, García Del Blanco B, López J, Dumont E, Delarochellière R, Ribeiro HB, Nombela-Franco L, Philippon F, Rodés-Cabau J (2014) Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation 129:1233–1243CrossRef Urena M, Webb JG, Tamburino C, Muñoz-García AJ, Cheema A, Dager AE, Serra V, Amat-Santos IJ, Barbanti M, Immè S, Briales JHA, Benitez LM, Al Lawati H, Cucalon AM, García Del Blanco B, López J, Dumont E, Delarochellière R, Ribeiro HB, Nombela-Franco L, Philippon F, Rodés-Cabau J (2014) Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation 129:1233–1243CrossRef
26.
go back to reference Fujita B, Schmidt T, Bleiziffer S, Bauer T, Beckmann A, Bekeredjian R, Möllmann H, Walther T, Landwehr S, Hamm C, Beyersdorf F, Katus HA, Harringer W, Ensminger S, Frerker C (2019) Impact of new pacemaker implantation following surgical and transcatheter aortic valve replacement on 1-year outcome. Eur J Cardiothorac Surg. 57(1):151–159CrossRef Fujita B, Schmidt T, Bleiziffer S, Bauer T, Beckmann A, Bekeredjian R, Möllmann H, Walther T, Landwehr S, Hamm C, Beyersdorf F, Katus HA, Harringer W, Ensminger S, Frerker C (2019) Impact of new pacemaker implantation following surgical and transcatheter aortic valve replacement on 1-year outcome. Eur J Cardiothorac Surg. 57(1):151–159CrossRef
27.
go back to reference Fadahunsi OO, Olowoyeye A, Ukaigwe A, Li Z, Vora AN, Vemulapalli S, Elgin E, Donato A (2016) Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the US Society of thoracic surgeons/american college of cardiology TVT registry. JACC Cardiovasc Interv. 9:2189–2199CrossRef Fadahunsi OO, Olowoyeye A, Ukaigwe A, Li Z, Vora AN, Vemulapalli S, Elgin E, Donato A (2016) Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the US Society of thoracic surgeons/american college of cardiology TVT registry. JACC Cardiovasc Interv. 9:2189–2199CrossRef
28.
go back to reference Kapadia SR, Huded CP, Kodali SK, Svensson LG, Tuzcu EM, Baron SJ, Cohen DJ, Miller DC, Thourani VH, Herrmann HC, Mack MJ, Szerlip M, Makkar RR, Webb JG, Smith CR, Rajeswaran J, Blackstone EH, Leon MB (2018) PARTNER trial investigators. Stroke after surgical versus transfemoral transcatheter aortic valve replacement in the PARTNER trial. J Am Coll Cardiol. 72:2415–2426CrossRef Kapadia SR, Huded CP, Kodali SK, Svensson LG, Tuzcu EM, Baron SJ, Cohen DJ, Miller DC, Thourani VH, Herrmann HC, Mack MJ, Szerlip M, Makkar RR, Webb JG, Smith CR, Rajeswaran J, Blackstone EH, Leon MB (2018) PARTNER trial investigators. Stroke after surgical versus transfemoral transcatheter aortic valve replacement in the PARTNER trial. J Am Coll Cardiol. 72:2415–2426CrossRef
29.
go back to reference Soundhar A, Udesh R, Mehta A, Schindler J, Jeevanantham V, Gleason T, Thirumala PD (2017) Delirium following transcatheter aortic valve replacement: national inpatient sample analysis. J Cardiothorac Vasc Anesth. 31:1977–1984CrossRef Soundhar A, Udesh R, Mehta A, Schindler J, Jeevanantham V, Gleason T, Thirumala PD (2017) Delirium following transcatheter aortic valve replacement: national inpatient sample analysis. J Cardiothorac Vasc Anesth. 31:1977–1984CrossRef
30.
go back to reference Husser O, Fujita B, Hengstenberg C, Frerker C, Beckmann A, Möllmann H, Walther T, Bekeredjian R, Böhm M, Pellegrini C, Bleiziffer S, Lange R, Mohr F, Hamm C, Bauer T, Ensminger S (2018) Conscious sedation versus general anesthesia in transcatheter aortic valve replacement: the German Aortic Valve Registry. JACC Cardiovasc Interv. 11:567–578CrossRef Husser O, Fujita B, Hengstenberg C, Frerker C, Beckmann A, Möllmann H, Walther T, Bekeredjian R, Böhm M, Pellegrini C, Bleiziffer S, Lange R, Mohr F, Hamm C, Bauer T, Ensminger S (2018) Conscious sedation versus general anesthesia in transcatheter aortic valve replacement: the German Aortic Valve Registry. JACC Cardiovasc Interv. 11:567–578CrossRef
31.
go back to reference Ehret C, Rossaint R, Foldenauer AC, Stoppe C, Stevanovic A, Dohms K, Hein M, Schälte G (2017) Is local anaesthesia a favourable approach for transcatheter aortic valve implantation? A systematic review and meta-analysis comparing local and general anaesthesia. BMJ Open. 7:e016321CrossRef Ehret C, Rossaint R, Foldenauer AC, Stoppe C, Stevanovic A, Dohms K, Hein M, Schälte G (2017) Is local anaesthesia a favourable approach for transcatheter aortic valve implantation? A systematic review and meta-analysis comparing local and general anaesthesia. BMJ Open. 7:e016321CrossRef
32.
go back to reference Dehédin B, Guinot PG, Ibrahim H, Allou N (2011) Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth. 25:1036–1043CrossRef Dehédin B, Guinot PG, Ibrahim H, Allou N (2011) Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth. 25:1036–1043CrossRef
33.
go back to reference Maas EHA, Pieters BMA, Van de Velde M, Rex S (2016) General or local anesthesia for TAVI? A systematic review of the literature and meta-analysis. CPD. 22:1868–1878CrossRef Maas EHA, Pieters BMA, Van de Velde M, Rex S (2016) General or local anesthesia for TAVI? A systematic review of the literature and meta-analysis. CPD. 22:1868–1878CrossRef
34.
go back to reference Pressler A, Förschner L, Hummel J, Haller B, Christle JW, Halle M (2018) Long-term effect of exercise training in patients after transcatheter aortic valve implantation: Follow-up of the SPORT:TAVI randomised pilot study. Eur J Prev Cardiol. 25:794–801CrossRef Pressler A, Förschner L, Hummel J, Haller B, Christle JW, Halle M (2018) Long-term effect of exercise training in patients after transcatheter aortic valve implantation: Follow-up of the SPORT:TAVI randomised pilot study. Eur J Prev Cardiol. 25:794–801CrossRef
35.
go back to reference Pressler A, Christle JW, Lechner B, Grabs V, Haller B, Hettich I, Jochheim D, Mehilli J, Lange R, Bleiziffer S, Halle M (2016) Exercise training improves exercise capacity and quality of life after transcatheter aortic valve implantation: A randomized pilot trial. Am Heart J. 182:44–53CrossRef Pressler A, Christle JW, Lechner B, Grabs V, Haller B, Hettich I, Jochheim D, Mehilli J, Lange R, Bleiziffer S, Halle M (2016) Exercise training improves exercise capacity and quality of life after transcatheter aortic valve implantation: A randomized pilot trial. Am Heart J. 182:44–53CrossRef
36.
go back to reference Pulignano G, Gulizia MM, Baldasseroni S, Bedogni F, Cioffi G, Indolfi C, Romeo F, Murrone A, Musumeci F, Parolari A, Patanè L, Pino PG, Mongiardo A, Spaccarotella C, Di Bartolomeo R, Musumeci G (2017) ANMCO/SIC/SICI-GISE/SICCH executive summary of consensus document on risk stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement. Eur Heart J Suppl. 19:D354–D369CrossRef Pulignano G, Gulizia MM, Baldasseroni S, Bedogni F, Cioffi G, Indolfi C, Romeo F, Murrone A, Musumeci F, Parolari A, Patanè L, Pino PG, Mongiardo A, Spaccarotella C, Di Bartolomeo R, Musumeci G (2017) ANMCO/SIC/SICI-GISE/SICCH executive summary of consensus document on risk stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement. Eur Heart J Suppl. 19:D354–D369CrossRef
Metadata
Title
Transcatheter aortic valve implantation in nonagenarians: insights from the German Aortic Valve Registry (GARY)
Authors
J. Blumenstein
H. Möllmann
S. Bleiziffer
T. Bauer
S. Ensminger
R. Bekeredjian
T. Walther
C. Frerker
F. Beyersdorf
C. Hamm
A. Beckmann
Publication date
01-09-2020
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 9/2020
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-020-01601-4

Other articles of this Issue 9/2020

Clinical Research in Cardiology 9/2020 Go to the issue